Intravenous (IV) Therapy and Vein Access: Global Markets 2016-2021

News provided by

Jul 06, 2017, 07:00 ET

DUBLIN, July 6, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Intravenous (IV) Therapy and Vein Access: Global Markets" report to their offering.

The Global Intravenous (IV) Therapy and Vein Access Market Should Reach $29 Billion by 2021 from $21.6 Billion in 2016 at a CAGR of 6.1%, from 2016 to 2021

Growing emphasis on cost-effectiveness and cost-containment at health care facilities along with technological advances have enabled the safe and effective use of IV therapies. This is driving steady growth of the IV therapy and vein access devices market. This report focuses on the global market of IV therapy and vein access devices and provides an updated review that includes applications in various care facility settings.

The scope of this study encompasses different types of IV solutions and devices used for therapeutic purposes. BCC Research studied and analyzed the market for key components including different types of intravenous solutions and sets, infusion pumps and vein access devices (IV catheters). This report covers the associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy. In addition, the study also covers the market projections, market leaders and market shares for the global IV therapy market.

The market is dominated by a few major players including B. Braun Melsungen AG; Baxter International Inc.; Becton Dickinson and Co. (CareFusion Corp.); C. R. Bard, Inc.; Fresenius Kabi AG; Hospira Inc. (now part of ICU Medical Inc.); Medtronic plc.; Smiths Group plc. (Smiths Medical) and Teleflex Inc.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Intravenous Therapy Overview

The Human Circulatory System
Definition of Infusion Therapy
Definition of Intravenous Therapy
Types of IV Infusion
Methods of IV Infusion
Advantages and Disadvantages of Intravenous (IV) Therapy
Historical Development of Intravenous Therapy
General Principles of IV Therapy
IV Solutions
Venous Access Devices (IV Catheters)

4: Regulatory Aspects

FDA Recalls and Safety Alerts
Safety Alerts for IV Solution
Recalls and Safety Communications for IV Devices (Infusion Pumps and IV Catheters)
New Approvals

5: New Developments/Technological Innovations

New Developments in the Field of IV Solutions and Sets
New Developments in the Field of IV Infusion Pumps
New Developments in the Field of IV Catheters

6: Market Analysis

7: Industry Structure

IV Solutions and Sets
Infusion Pumps
Vein Access Devices (IV Catheters)

8: Market by Application

9: Patent Analysis

Award Year
Product Type
Company
Country Breakdown
Assignee

10: Current Outlook

Factors Affecting Intravenous (IV) Therapy and Venous Access Devices Market
Collaborations - Mergers and Acquisitions

11: Company Profiles

Angel Electronic Equipment Co. Ltd.
Angiodynamics Inc.
Animas Corp.
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson And Company
Caesarea Medical Electronics Ltd.
Cequr SA
Codman & Shurtleff Inc.
Cook Medical Inc.
C.R. Bard, Inc.
Debiotech S. A.
Edwards Lifesciences Corp.
Fresenius Kabi AG
Halyard Health, Inc.
Health Line International Corp.
Icu Medical Inc.
Insulet Corp.
Iradimed Corp.
Medical Components Inc.
Medtronic Plc
Micrel Medical Devices SA
Moog Inc.
Otsuka Pharmaceutical Co. Ltd.
Roche Diagnostics
Smiths Medical
Sooil Developments Co., Ltd
Tandem Diabetes Care Inc.
Teleflex Inc.
Terumo Medical Corp.
Valeritas Inc.
Vygon SA
Zyno Medical Llc

12: Appendix: Abbreviations

For more information about this report visit https://www.researchandmarkets.com/research/3vvvmb/intravenous_iv

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets